Morphine Adverse Reaction Completed Phase Trials for Palonosetron (DB00377)

IndicationStatusPhase
DBCOND0043635 (Morphine Adverse Reaction)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01952626Prevention of Intrathecal Morphine Induced Pruritus: Comparison of Ondansetron and PalonosetronPrevention